Global Positron Emission Tomography Scanners Market Size, Forecast, and Trend Highlights Over 2022 - 2031
Base Year |
2021 |
Forecast Year |
2022-2031 |
CAGR |
~5% |
The global positron emission tomography scanners market is estimated to garner significant revenue by the end of 2031 by growing at a CAGR of ~5% over the forecast period, i.e., 2022 – 2031.
Further, the market generated impressive revenue in the year 2021. The growth of the market can be attributed primarily to the rising incidence of cancer worldwide. As per the statistics of the American Cancer Society, 1.9 million new cancer cases are expected to be diagnosed by the end of 2022, and 609,360 cancer deaths are expected to occur in the United States. Moreover, growing demand for non-invasive medical procedures, adoption of hybrid imaging, and medical tourism are some of the other factors expected to enlarge global positron emission tomography scanners market size during the forecast period.
Get more information on this report: Request Sample PDF
Positron emission tomography (PET) scanners are widely used for medical examinations, providing information on the activity of cells in the human body in a non-invasive way. For PET scans, radioactive drugs (tracers) are generally injected into the hand or arm to detect abnormal metabolism in diseases. This tracer then collects where metabolic or biochemical activity is higher, which often identifies the area of disease. Global positron emission tomography scanners market trends such as molecular imaging approaches for breast cancer and hybrid imaging systems including PET/CT and PET/MRI are expected to drive market growth during the forecast period. Furthermore, growing demand for PET analysis in radiopharmaceuticals along with developments in nuclear medicine imaging is expected to enlarge the global positron emission tomography scanners market size during forecast period. Nuclear medicine is widely used in hospitals, owing to the extensive application of radiopharmaceuticals in treatment. For instance, nuclear medicine procedures account for over 35 million procedures annually, and demand for radioisotopes is rising by up to 4% each year.
Global Positron Emission Tomography Scanners Market: Growth Drivers and Challenges
Growth Drivers
-
Rising Prevalence of Breast Cancer Around the World -according to the World Health Organization, in 2020, breast cancer affected 2.3 million women and caused 685 000 deaths worldwide. By the end of 2020, 7.8 million women were diagnosed with breast cancer. There is a high rate of mortality and morbidity associated with breast cancer in women worldwide. Imaging biomarkers have provided clinically useful information for breast cancer diagnosis and treatment. There have been several studies published and products launched regarding PET-based imaging of breast cancer.
-
Developing Guidelines for Radiopharmaceutical Manufacturing- for instance, the International Atomic Energy Agency sanctioned a project in February 2020, offering guidance and technical assistance on manufacturing cyclotron-based gallium-68 radioisotopes and radiopharmaceuticals.
-
Increasing Cases of Huntington's Disease Worldwide - it is estimated that approximately 40,000 Americans suffer from Huntington's disease and another 300,000 are at risk for the disease per year. The symptoms usually appear between the ages of 25 and 50.
-
Increased Government Expenditures on Healthcare-according to World Bank data, Global health expenditures increased from 9.7% in 2018 to 9.84% in 2019.
-
Growing Geriatric Population Across the Globe - according to the data released by World Bank, the number of geriatric people at the end of 2021 was 747,238,580 worldwide.
Challenges
- Higher Cost Associated With the Positron Emission Tomography Scanners
- Stringent Set of Regulatory Guidelines For the Product
- Short Life Expectancy of the Scanner
The global positron emission tomography scanners market is segmented and analyzed for demand and supply by end user into hospitals, diagnostic centers, PET centers, and research institutes. Among these segments, the end user segment is anticipated to capture the largest market size in the global positron emission tomography scanners market owing to the increasing number of medical professionals specialized in PET and the rising demand for early diagnosis and treatment of cancer. Additionally, the growing use of PET scanners in hospitals is expected to drive segment growth over the forecast period. It was observed that in 2019 approximately 2,050,000 clinical PET scans were performed in about 2,300 hospitals in the United States. In addition, the number of PET scans performed in 2018 increased by 6% over 2017.
Major Macro-Economic Indicators Impacting the Market Growth
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Global Positron Emission Tomography Scanners Market Regional Synopsis
Regionally, the global positron emission tomography scanners market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2031. Rapid technical developments, increasing awareness of early diagnosis, and the rising prevalence of the geriatric population in the region are major factors estimated to drive the market growth during the forecast period. For instance, it was observed that, every year, approximately 2 to 2.5 million PET scans are performed in the United States. Moreover, the increasing expenditure on healthcare is expected to propel the growth of the market in the region over the forecast period. For instance, in 2018, the United States spent 16% of its gross domestic product (GDP) on health care.
Get more information on this report: Request Sample PDF
The global positron emission tomography scanners market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Market Segmentation
Our in-depth analysis of the global positron emission tomography scanners market includes the following segments:
By Application |
|
|
|
|
|
By Product Type |
|
|
|
By Detector Type |
|
|
|
|
|
|
|
|
|
By End User |
|
|
|
|
|
|
Top Featured Companies Dominating the Global Positron Emission Tomography Scanners Market
- General Electric Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- General de Equipment for Medical Imaging, S.A.
- Koninklijke Philips N.V.
- Neusoft Corporation
- Siemens Healthcare GmbH
- Segami Corporation
- Spectrum Dynamics Medical, Inc.
- Hitachi, Ltd.
- Cerveau Technologies, Inc.
- Radiology Oncology System, Inc.